subscribeSubscribe
Teva CEO, after 120 days, preps grand strategic reveal

Teva CEO, after 120 days, preps grand strategic reveal
Nicole DeFeudis ENDPTS
11 May 2023
Share Share
Viatris leans in on brand drug portfolio for future growth

Viatris leans in on brand drug portfolio for future growth
Beth Snyder Bulik ENDPTS
08 May 2023
Share Share
Across Europe - on average - 26% of all generic medicines have disappeared

Across Europe - on average - 26% of all generic medicines have disappeared
MEDICINEFOREUROPE
04 May 2023
Share Share
Biogen finally scores win in its fight to prevent copycats of MS drug in the EU

Biogen finally scores win in its fight to prevent copycats of MS drug in the EU
Katherine Lewin ENDPTS
04 May 2023
Share Share
Bristol-Myers Squibb 1Q Results

Bristol-Myers Squibb 1Q Results
BUSINESSWIRE
03 May 2023
Share Share
Amgen sues Novartis to block generic osteoporosis, bone cancer drugs

Amgen sues Novartis to block generic osteoporosis, bone cancer drugs
REUTERS
03 May 2023
Share Share
Hikma Sees Signs Of A Bounceback For Generics

Hikma Sees Signs Of A Bounceback For Generics
David Wallace PHARMAINTELIGENCE
02 May 2023
Share Share
Dr Reddy`s Labs launches generic injection in US

Dr Reddy`s Labs launches generic injection in US
ECONOMIC TIMES
21 Apr 2023
Share Share
Elite Pharmaceuticals Files ANDA with US FDA to Market Antimetabolite Product

Elite Pharmaceuticals Files ANDA with US FDA to Market Antimetabolite Product
ACCESSWIRE
20 Apr 2023
Share Share
FDA updates generic transdermal and topical delivery systems guidances

FDA updates generic transdermal and topical delivery systems guidances
RAPS
12 Apr 2023
Share Share